NCT03819985View on ClinicalTrials.gov

Shorter Course, Hypofractionated Pre-Surgery Radiation Therapy in Treating Patients With Localized, Resectable Soft Tissue Sarcoma of the Extremity of Superficial Trunk

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

December 17, 2018

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Resectable Soft Tissue SarcomaStage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Interventions
RADIATION

Hypofractionated Radiation Therapy

Undergo hypofractionated RT

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03819985 - Shorter Course, Hypofractionated Pre-Surgery Radiation Therapy in Treating Patients With Localized, Resectable Soft Tissue Sarcoma of the Extremity of Superficial Trunk | Biotech Hunter | Biotech Hunter